Clinical trials

5

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Surgical Treatment for Gingival Recessions After Orthodontic Treatment

Modification of the periodontal soft tissue phenotype and coverage of exposed root surfaces in patients who have undergone orthodontic treatment.

Participants needed: 75
Trial details
Phase: Phase 2, Phase 3Age: 18-70Biological sex: AllType: InterventionalSponsor: Aziz Aliyev Azerbaijan State Advanced Training Institute for DoctorsUpdated: Aug 13, 2026Locations: 1
Eligibility criteria

Systemically healthy patients [+3]

Smokers [+3]

Status: Recruiting

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

International, post-authorisation non-interventional study to evaluate real-life effectiveness, safety and utilisation patterns of Octapharma's FVIII concentrates Nuwiq, Octanate, and Wilate in previously untreated and minimally treated severe haemophilia A patients in routine clinical practice.

Participants needed: 200
Trial details
Biological sex: AllType: ObservationalSponsor: OctapharmaUpdated: Jun 2, 2026Locations: 59
Eligibility criteria

Male and female patients of any age and ethnicity [+9]

Diagnosis with a coagulation disorder other than haemophilia A [+3]

Status: Recruiting

Investigation of Pain Perception According to Gender in Individuals With Scoliosis

The aim of this study is to evaluate whether pain perception under spinal pressure created on a physiotherapy roller differs according to gender in individuals diagnosed with scoliosis.

Participants needed: 50
Trial details
Age: 18-45Biological sex: AllType: InterventionalSponsor: Uskudar UniversityUpdated: Apr 9, 2026Locations: 1
Eligibility criteria

Having a clinical or radiological diagnosis of scoliosis [+3]

Having a history of neurological disease [+2]

Status: Recruiting

Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease

Investigation of the effectiveness of extracorporeal shock wave therapy in the treatment of Peyronie's disease.

Participants needed: 50
Trial details
Age: 18-65Biological sex: MaleType: InterventionalSponsor: Uskudar UniversityUpdated: Jan 16, 2026Locations: 1
Eligibility criteria

Male individuals aged 18-65 years. [+2]

Acute inflammatory stage (painful, progressive) [+5]

Status: Recruiting

Multi-level Child Mental Health Interventions in Azerbaijan

To improve mental health outcomes among children aged 7-14 from low-income families in Azerbaijan, this study will refine and test three evidence-based intervention approaches: family-strengthening intervention; trauma-focused mental health services; and economic empowerment in the form of Child Savings Accounts. Based on prior research on the mental health of deinstitutionalized children conducted by this U.S.-Azerbaijani team in collaboration with a local Community Collaborative Board, these intervention components have been adapted to maximize fit to the cultural context of Azerbaijan. In this study, the adapted interventions will be tested with 600 child-caregiver dyads in a trial using the Multiphase Optimization Strategy (MOST) to compare different intervention components and identify the most optimal combination. Given the limited human and financial resources in low- and middle-income countries (LMICs), it will be important to identify whether each of these interventions is necessary and/or sufficient for improving the mental health of children. The study will test the effects of each intervention component on children's mental health outcomes (symptoms of depression, anxiety; disruptive behaviors; post-traumatic symptoms;), on associated cognitive and social processes (e.g., attention, emotion recognition bias) and functional outcomes (e.g., academic performance). The study will also examine the mediating pathway associated with each intervention component.

Participants needed: 1,200
Trial details
Age: 7-14Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Apr 6, 2025Locations: 2
Eligibility criteria

The child is between ages 7 and 14; [+3]